Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment

J Allergy Clin Immunol. 2004 Feb;113(2):355-8. doi: 10.1016/j.jaci.2003.10.065.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Administration, Topical
  • Child
  • Conjunctivitis, Allergic / drug therapy*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Ointments / administration & dosage
  • Ophthalmic Solutions / administration & dosage
  • Tacrolimus / administration & dosage
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Ointments
  • Ophthalmic Solutions
  • Tacrolimus